Acelyrin Inc (NASDAQ: SLRN) closed the day trading at $8.16 up 10.12% from the previous closing price of $7.41. In other words, the price has increased by $+0.75 from its previous closing price. On the day, 1131038 shares were traded. SLRN stock price reached its highest trading level at $8.45 during the session, while it also had its lowest trading level at $7.44.
Ratios:
For a better understanding of SLRN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.88 and its Current Ratio is at 11.88. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on December 13, 2023, initiated with a Equal Weight rating and assigned the stock a target price of $11.
On December 08, 2023, Citigroup started tracking the stock assigning a Neutral rating and target price of $8.
Morgan Stanley Downgraded its Overweight to Equal-Weight on September 13, 2023, while the target price for the stock was maintained at $19.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 20 when Lin Shao-Lee sold 15,701 shares for $7.60 per share. The transaction valued at 119,403 led to the insider holds 1,587,335 shares of the business.
Lin Shao-Lee sold 10,691 shares of SLRN for $79,188 on Jan 02. The Chief Executive Officer now owns 1,603,036 shares after completing the transaction at $7.41 per share. On May 09, another insider, Westlake BioPartners Fund II, , who serves as the 10% Owner of the company, bought 1,250,000 shares for $18.00 each. As a result, the insider paid 22,500,000 and bolstered with 9,790,729 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLRN now has a Market Capitalization of 720.80M and an Enterprise Value of 7.11M.
Stock Price History:
Over the past 52 weeks, SLRN has reached a high of $29.88, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is 7.39, while the 200-Day Moving Average is calculated to be 14.50.
Shares Statistics:
Over the past 3-months, SLRN traded about 1.21M shares per day on average, while over the past 10 days, SLRN traded about 1.06M shares per day. A total of 92.70M shares are outstanding, with a floating share count of 60.30M. Insiders hold about 37.99% of the company’s shares, while institutions hold 71.21% stake in the company. Shares short for SLRN as of Jan 31, 2024 were 6.45M with a Short Ratio of 5.34, compared to 6.77M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 6.62% and a Short% of Float of 8.42%.
Earnings Estimates
Current recommendations for the stock of the company come from 7 analysts. The consensus estimate for the next quarter is -$1.01, with high estimates of -$0.8 and low estimates of -$1.29.
Analysts are recommending an EPS of between -$4.24 and -$11.1 for the fiscal current year, implying an average EPS of -$7.4. EPS for the following year is -$4.2, with 7 analysts recommending between -$3.38 and -$6.8.
